Literature DB >> 33402390

A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.

Sai Ma1,2, Bo Zhou3, Qian Yang2, Yunzhi Pan4, Wei Yang3, Stephen J Freedland5, Ling-Wen Ding6, Michael R Freeman3, Joshua J Breunig7, Neil A Bhowmick2, Jian Pan8, H Phillip Koeffler2,6, De-Chen Lin9.   

Abstract

Although obesity is one of the strongest risk factors for esophageal adenocarcinoma, the molecular mechanisms underlying this association remain unclear. We recently identified four esophageal adenocarcinoma-specific master regulator transcription factors (MRTF) ELF3, KLF5, GATA6, and EHF. In this study, gene-set enrichment analysis of both esophageal adenocarcinoma patient samples and cell line models unbiasedly underscores fatty acid synthesis as the central pathway downstream of three MRTFs (ELF3, KLF5, GATA6). Further characterizations unexpectedly identified a transcriptional feedback loop between MRTF and fatty acid synthesis, which mutually activated each other through the nuclear receptor, PPARG. MRTFs cooperatively promoted PPARG transcription by directly regulating its promoter and a distal esophageal adenocarcinoma-specific enhancer, leading to PPARG overexpression in esophageal adenocarcinoma. PPARG was also elevated in Barrett's esophagus, a recognized precursor to esophageal adenocarcinoma, implying that PPARG might play a role in the intestinal metaplasia of esophageal squamous epithelium. Upregulation of PPARG increased de novo synthesis of fatty acids, phospholipids, and sphingolipids as revealed by mass spectrometry-based lipidomics. Moreover, ChIP-seq, 4C-seq, and a high-fat diet murine model together characterized a novel, noncanonical, and cancer-specific function of PPARG in esophageal adenocarcinoma. PPARG directly regulated the ELF3 super-enhancer, subsequently activating the transcription of other MRTFs through an interconnected regulatory circuitry. Together, elucidation of this novel transcriptional feedback loop of MRTF/PPARG/fatty acid synthesis advances our understanding of the mechanistic foundation for epigenomic dysregulation and metabolic alterations in esophageal adenocarcinoma. More importantly, this work identifies a potential avenue for prevention and early intervention of esophageal adenocarcinoma by blocking this feedback loop. SIGNIFICANCE: These findings elucidate a transcriptional feedback loop linking epigenomic dysregulation and metabolic alterations in esophageal adenocarcinoma, indicating that blocking this feedback loop could be a potential therapeutic strategy in high-risk individuals. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33402390      PMCID: PMC8026506          DOI: 10.1158/0008-5472.CAN-20-0652

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  56 in total

1.  Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling.

Authors:  Beatriz Sanchez-Espiridion; Dong Liang; Jaffer A Ajani; Su Liang; Yuanqing Ye; Michelle A T Hildebrandt; Jian Gu; Xifeng Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2015-05-19       Impact factor: 11.382

2.  Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet.

Authors:  Xing-He Wang; Chun-Yan Li; Ishfaq Muhammad; Xiu-Ying Zhang
Journal:  Environ Toxicol Pharmacol       Date:  2016-04-30       Impact factor: 4.860

3.  Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

Authors:  Yvette Bren-Mattison; Vicki Van Putten; Daniel Chan; Robert Winn; Mark W Geraci; Raphael A Nemenoff
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

4.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

Authors:  S A Kliewer; S S Sundseth; S A Jones; P J Brown; G B Wisely; C S Koble; P Devchand; W Wahli; T M Willson; J M Lenhard; J M Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

6.  Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.

Authors:  Jennifer Drahos; Lin Li; Susan S Jick; Michael B Cook
Journal:  Cancer Epidemiol       Date:  2016-03-09       Impact factor: 2.984

Review 7.  Fatty acids, eicosanoids and PPAR gamma.

Authors:  Rachel Marion-Letellier; Guillaume Savoye; Subrata Ghosh
Journal:  Eur J Pharmacol       Date:  2015-11-26       Impact factor: 4.432

8.  Fatty Acids, Obesity and Insulin Resistance.

Authors:  Peter Arner; Mikael Rydén
Journal:  Obes Facts       Date:  2015       Impact factor: 3.942

9.  Single cell RNA-seq reveals profound transcriptional similarity between Barrett's oesophagus and oesophageal submucosal glands.

Authors:  Richard Peter Owen; Michael Joseph White; David Tyler Severson; Barbara Braden; Adam Bailey; Robert Goldin; Lai Mun Wang; Carlos Ruiz-Puig; Nicholas David Maynard; Angie Green; Paolo Piazza; David Buck; Mark Ross Middleton; Chris Paul Ponting; Benjamin Schuster-Böckler; Xin Lu
Journal:  Nat Commun       Date:  2018-10-15       Impact factor: 14.919

10.  Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.

Authors:  Connor Rogerson; Samuel Ogden; Edward Britton; Yeng Ang; Andrew D Sharrocks
Journal:  Elife       Date:  2020-09-03       Impact factor: 8.140

View more
  10 in total

Review 1.  Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.

Authors:  Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

2.  Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition.

Authors:  Samuel Ogden; Kashmala Carys; Ibrahim Ahmed; Jason Bruce; Andrew D Sharrocks
Journal:  Oncogene       Date:  2022-09-24       Impact factor: 8.756

3.  EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.

Authors:  Akinsola Oyelakin; Kasturi Bala Nayak; Alexandra Ruth Glathar; Christian Gluck; Theresa Wrynn; Antonio Tugores; Rose-Anne Romano; Satrajit Sinha
Journal:  NAR Cancer       Date:  2022-05-27

4.  Construction and analysis of competing endogenous RNA network and patterns of immune infiltration in abdominal aortic aneurysm.

Authors:  Liang Chen; Shuangshuang Wang; Zheyu Wang; Yuting Liu; Yi Xu; Shuofei Yang; Guanhua Xue
Journal:  Front Cardiovasc Med       Date:  2022-08-04

Review 5.  SP and KLF Transcription Factors in Cancer Metabolism.

Authors:  Emilia J Orzechowska-Licari; Joseph F LaComb; Aisharja Mojumdar; Agnieszka B Bialkowska
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 6.  Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.

Authors:  Meng-Ying Cui; Xing Yi; Zhen-Zhen Cao; Dan-Xia Zhu; Jun Wu
Journal:  J Oncol       Date:  2022-09-05       Impact factor: 4.501

7.  Super-enhancer-associated INSM2 regulates lipid metabolism by modulating mTOR signaling pathway in neuroblastoma.

Authors:  Haibo Cao; Ran Zhuo; Zimu Zhang; Jianwei Wang; Yanfang Tao; Randong Yang; Xinyi Guo; Yanling Chen; Siqi Jia; Ye Yao; Pengcheng Yang; Juanjuan Yu; Wanyan Jiao; Xiaolu Li; Fang Fang; Yi Xie; Gen Li; Di Wu; Hairong Wang; Chenxi Feng; Yunyun Xu; Zhiheng Li; Jian Pan; Jian Wang
Journal:  Cell Biosci       Date:  2022-09-16       Impact factor: 9.584

8.  Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract.

Authors:  Xiaomeng Hu; Shengchao Zhao; Yi Cai; Shasank S Swain; Liangliang Yao; Wei Liu; Tingdong Yan
Journal:  Biomed Res Int       Date:  2022-09-16       Impact factor: 3.246

9.  Augmented CPT1A Expression Is Associated with Proliferation and Colony Formation during Barrett's Tumorigenesis.

Authors:  Joshua N Bernard; Vikram Chinnaiyan; Thomas Andl; Gregoire F Le Bras; M Nasar Qureshi; Deborah A Altomare; Claudia D Andl
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

10.  Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma.

Authors:  Gang Wang; Fangfang Qu; Shouyong Liu; Jincai Zhou; Yi Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.